IndiraBrarMD

Infectious Disease • Troy, MI

Physician

Join to view full profile

Dr. Brar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Brar's full profile

Already have an account?

Office
2825 Livernois Rd
Troy, MI 48083
Phone+1 313-916-2600

Education & Training

Boston University Medical CenterFellowship, Infectious Disease, 1994 - 1997
UMass Chan Medical SchoolResidency, Internal Medicine, 1991 - 1993
SUNY Downstate Health Sciences UniversityInternship, Internal Medicine, 1990 - 1991
Christian Medical College LudhianaClass of 1987

Certifications & Licensure

MI State Medical License 1998 - 2026
MA State Medical License 1992 - 2003
American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Post-Exposure Prophylaxis in Health Care Workers Start of enrollment: 2011 Feb 01
Completed
Phase 4

Publications & Presentations

PubMed

13 citations
Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Black Americans With HIV-1: A Randomized Phase 3b, Multicenter, Open-Label Study.
Debbie Hagins, Princy Kumar, Michael S. Saag, Anson K Wurapa, Indira Brar
Journal of Acquired Immune Deficiency Syndromes. 2021-09-01
97 citations
Switching to fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide from dolutegravir plus abacavir and lamivudine in virologically suppressed adults with HI...
Jean-Michel Molina, Douglas J. Ward, Indira Brar, Anthony Mills, Hans-Jürgen Stellbrink
The Lancet. HIV. 2018-07-01
422 citations
Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit.
Geehan Suleyman, Raef Fadel, Kelly M. Malette, Charles Hammond, Hafsa Abdulla
JAMA Network Open. 2020-06-01

Press Mentions

Global Health Research Collaborative Panel Discussions Open to All Beginning July 22July 11th, 2022
OTC Meds, Supplements, and Other Drugs May Interact with HIV AntiretroviralsMay 23rd, 2022
Despite FDA Delay, Convalescent Plasma Trials Continue in MichiganAugust 20th, 2020
Join now to see all